Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Sales $ 296,986 $ 440,495
Cost of sales (249,421) (228,610)
Gross profit 47,565 211,885
Operating Expenses    
Selling and marketing 37,893 111,438
General and administrative 1,229,235 1,377,724
Depreciation and amortization 46,161 49,580
Total operating expenses 1,313,289 1,538,742
Loss from Operations (1,265,724) (1,326,857)
Other Expense (Income)    
Interest expense, net 30,233 121,623
Gains from foreign currency transactions (465) (47,523)
Total other expense 29,768 74,100
Net Loss (1,295,492) (1,400,957)
Net loss attributable to non-controlling interest 42,645
Series B preferred stock dividends (179,770) (177,795)
Net Loss Attributable to Common Stockholders $ (1,432,617) $ (1,578,752)
Net Loss per Common Share $ (0.02) $ (0.03)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 60,271,082 47,818,263